A Study to Evaluate the Efficacy of PanCytoVir™ for the Treatment of Non-Hospitalized Patients With COVID-19 Infection
Clinical trial NCT05442983 · COMPLETED
Trial details
- NCT number
- NCT05442983
- Sponsor
- TrippBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-12
- Primary completion
- 2022-09-07
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.